Small Molecules
21 July 2017
ORYZON to Regain Rights to ORY-1001 (RG6016)19 July 2017
Alpha Tau Medical Secures Second Funding Round to Treat Solid Tumors With Alpha Radiation19 July 2017
Aldeyra Therapeutics Announces Last Patient Dosed in Dry Eye Disease Phase 2a Clinical Trial19 July 2017
Recordati: the European Commission approves Reagila® (cariprazine) for the treatment of schizophrenia18 July 2017
Repros Announces Proellex® Development Program Will Remain on Partial Clinical Hold by the FDANews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports